Poland· PL-100104819

Antinervinum

A valerianae radix product containing valerianae tinctura + crataegi tinctura + lupuli strobili tinctura, registered in Poland by Farmaceutyczne Produkty Bonifraterskie Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC N05CM09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAntinervinumATCN05CM09REGISTER NO.PL-100104819PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Valerianae radix is registered in 12 of 19 countries.

Countries holding a registration under ATC N05CM09 (valerianae radix), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Valerianae radix · ATC N05CM09

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Valerianae tinctura + Crataegi tinctura + Lupuli strobili tinctura
Manufacturer
Farmaceutyczne Produkty Bonifraterskie Sp. z o.o.
Country
Poland (PL)
ATC code
N05CM09
ATC class
Valerianae radix
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990905027
  • gtin
    05909990905010

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

59 interactions on record for valerianae radix.

Graded by severity as the source publishes them — 59 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valerianae radix · interactions on record

59 records

  • 59 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd68aa94-ab9c-4afa-ab28-b4756a6c076c
GET /v1/drugs/fd68aa94-ab9c-4afa-ab28-b4756a6c076c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Syrop",
  "source": "urpl",
  "strength": "(1032 mg + 903 mg + 645 mg)/5 ml",
  "packaging": "05909990905027 ¦ OTC ¦ 18110\n300 g\n05909990905010 ¦ OTC ¦ 48479\n200 g",
  "substance": "Valerianae tinctura 1032 mg/ 5 ml\n(1:4,0-4,5) ekstrahent: etanol 70% (v/v) + Crataegi tinctura 903 mg/ 5 ml\n(1:3,25-3,75) ekstrahent: etanol 60% (v/v) + Lupuli strobili tinctura 645 mg/ 5 ml\n(1:5) ekstrahent: etanol 70% (v/v)",
  "common_name": "Valerianae tinctura + Crataegi tinctura + Lupuli strobili tinctura",
  "pl_product_id": "100104819",
  "pozwolenie_nr": "09050",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about valerianae radix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.